Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Tower Semiconductor Ltd. Ordinary Shares (TSEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Tower Semiconductor Ltd. Ordinary Shares — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while Tower Semiconductor Ltd. Ordinary Shares trades at $207 (market cap $24.09B). The key difference: Tower Semiconductor Ltd. Ordinary Shares is far larger — about 2.7× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Tower Semiconductor Ltd. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Tower Semiconductor Ltd. Ordinary Shares for 6 Days on average.
| KYMR | TSEM | |
|---|---|---|
Market Cap | $8.87B | $24.09B |
Volume | 779,107 | 2,099,453 |
Sector | Health | Technology |
52-Week High | $127.31 | $316.85 |
52-Week Low | $55.80 | $72.74 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $8.26B | $22.75B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tower Semiconductor (TSEM) trades at $222.20, up 2.63% today, amid a bearish technical signal despite strong quarterly earnings beats. The stock faces resistance near $225 with support at $210. Recent news highlights expansion in silicon photonics and SiGe partnerships for AI infrastructure, positioning the company in high-growth segments. Revenue reached $1.57B in 2025 with a net income margin of 16.94%, though valuation ratios like P/E of 87.85 suggest premium pricing.
Outlook remains positive driven by AI-driven demand and strategic partnerships, but high valuation and technical bearishness pose near-term risks. Analysts project a $302 consensus price target, implying significant upside, yet investors should monitor execution on growth initiatives and competitive pressures in the semiconductor foundry space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Tower Semiconductor Ltd. Ordinary Shares
Tower Semiconductor is a specialty semiconductor foundry that manufactures analog and mixed-signal chips for other companies.
Read more on TSEM →
